Maxine Gowen

Maxine Gowen, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Aclaris Therapeutics, Inc. and Idera Pharmaceuticals, Inc. In total, 6 filings cover trades dated from 3 June 2022 to 5 June 2026.

Sales make up the whole of the open-market record (1 sale, €24). The rest of the record consists of 5 option exercises.

Most recently, on 8 June 2026, the filings show an option exercise in Aclaris Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.